期刊文献+

Inactivation of tumor suppressor TAp63 by hepatitis B virus X protein in hepatocellular carcinoma

原文传递
导出
摘要 Background: The hepatitis B virus X (HBx) protein plays a critical role in the initiation and progression of hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC). In the early stage of the disease, HBx facilitates tumor onset by inactivating the tumor suppressor p53. The p53-encoding gene, however, is frequently mutated or deleted as the cancer progresses to the late stage and, under such circumstance, the p53 homolog TAp63 can harness HCC growth by transactivating several important p53-target genes.Methods: To determine whether HBx regulates TAp63, we performed co-immunoprecipitation assay, real-time quantitative polymerase chain reaction, immunoblotting, and flow cytometry analysis in p53-null cancer cell lines, Hep3B and H1299.Results: HBx interacts with the transactivation domain of TAp63, as HBx was co-immunoprecipitated with TAp63 but not with ΔNp63. The interaction between HBx and TAp63 abolished transcriptional activity of TAp63, as evidenced by the reduction of the levels of its target genesp21 andPUMA, consequently leading to restricted apoptosis and augmented proliferation of HCC cells.Conclusion: HBV induces progression of HCC that harbors defective p53 by inhibiting the tumor suppressor TAp63.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2022年第14期1728-1733,共6页 中华医学杂志(英文版)
基金 supported by grants from the Beijing Municipal Institute of Public Medical Research Development and Reform Pilot Project(jingyiyan2019-6,jingyiyan2021-10) China Primary Health Care Foundation-YouAn Foundation of Liver Disease and AIDS(Scientific Research Project of Beijing YouAn Hospital,CCMU,2018) the National Natural Science Foundation of China(No.82072879).
  • 相关文献

参考文献4

二级参考文献6

共引文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部